Semaglutide GLP-1 has demonstrated superior efficacy for sustained weight loss and improvements in metabolic parameters
B12 supplementation may be particularly important if you are combining long-term semaglutide use with PPI therapy, as both can reduce B12 absorption through different mechanisms
Being open with your healthcare team about any compounds you are using including unlicensed or investigational products is essential for your safety and for accurate clinical assessment
Simple timing framework Baseline Discuss baseline labs before starting, especially if body weight, blood sugar, lipids, liver health, or kidney health are part of the research context
While injection-site irritation is well recognized, clinicians are increasingly observing broader skin changes in patients treated with semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and tirzepatide Read More GLP-1s and Dermatologic Reactions: Beyond Injection-Site Effects Dermatologic reactions linked to GLP-1 therapy are gaining attention as the use of glucagon-like peptide-1 receptor agonists continues to expand in diabetes and obesity care
.png?width=901&height=1201&name=Tirzepatide%20Image%20900x1200%20(vial%20only).png)